House investigators suggest former Trump advisor Peter Navarro steered coronavirus supply contracts to companies he favored
After former President Donald Trump ignored his advice to ramp up the procurement of coronavirus supplies before the United States was overwhelmed by the pandemic, former White House Trade Adviser Peter Navarro reportedly took it upon himself to get the job done. While some government officials, including Dr. Rick Bright, the former director of the Biomedical Advanced Research and Development Agency, have spoken admirably about how seriously Navarro took the pandemic, the House subcommittee on the coronavirus outbreak is concerned by his process, The Washington Post reports.
The subcommittee, chaired by Rep. James Clyburn (D-S.C.), alleges Navarro and other senior White House officials pursued "a haphazard and ineffective approach to procurement in which senior White House officials steered contracts to particular companies without adequate diligence or competition." One of those companies was Phlow, which was incorporated in January 2020 and had never manufactured drugs before. After a push from Navarro, BARDA awarded the firm with a $354 million contract, plus $458 million in options. A letter from the subcommittee explains Navarro was first introduced to Phlow's eventual CEO in November 2019, and the Post reports the company had "won Navarro's favor by making the argument that the United States was too dependent on Chinese manufacturing — a big concern" of his.
House investigators reportedly also obtained documents which reveal retired Gen. Jack Keane, a Trump ally, touted the company AirBoss, for which he was a paid consultant, to Navarro on March 22. That led to an immediate conversation between Airboss' brass and White House officials, the Post reports. The next day, the company reportedly submitted a $96.4 million proposal, and Navarro's team reportedly pressured the Federal Emergency Management Agency to finalize an updated version of the contract within a week. Read more at The Washington Post.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Warner Bros. explores sale amid Paramount bidsSpeed Read The media giant, home to HBO and DC Studios, has received interest from multiple buying parties
-
Gold tops $4K per ounce, signaling financial uneaseSpeed Read Investors are worried about President Donald Trump’s trade war
-
Electronic Arts to go private in record $55B dealspeed read The video game giant is behind ‘The Sims’ and ‘Madden NFL’
-
New York court tosses Trump's $500M fraud fineSpeed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in IntelSpeed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to ChinaSpeed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with DisneySpeed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B dealSpeed Read Tesla has signed a deal to get its next-generation chips from Samsung



